Kelsey C. Bertrand, MD

Department or Service

Location

  • Texas Medical Center

Phone: 832-822-4200
Fax: 832-825-1453

Contact Information

6701 Fannin St.
Houston, TX 77030

Clinical Fellow, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
University of Queensland medical school Doctor of Medicine 2013
University of Toronto/ The Hospital for Sick Children masters Master of Science, Laboratory Medicine and Pathobiology 2009
University of Guelph other Bachelor of Science, Biological Science 2007
Cleveland Clinic residency Pediatrics

About Kelsey C. Bertrand

Dr. Kelsey Bertrand is a clinical fellow in the Cancer and Hematology Centers where she is specializing in pediatric hematology/oncology.

Organization

Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member

Selected Publications

Mack SC, Agnihotri S, Witt H, Shih DJ, Wang X, Zayne K, Barszczyk M, Ramaswamy V, Bertrand KC, Remke M, Yao Y, Ryzhova M, Massimi L, Grajkowska W, Lach B, Philips J, Gupta N, Weiss WA, Guha A,, Hawkins C, Croul S, Bader GD, Rutka JT, Zadeh G, Pfister SM, Korshunov A, Taylor MD. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype. Clin Cancer Res. 2015; 21(16):3750-3758.

Faria CC, Agnihotri S, Mack SC, Golbourn BJ, Diaz RJ, Olsen S, Bryant M, Bebenek M, Wang X, Bertrand KC, Kushida M, Head R, Clark I, Dirks P, Smith CA, Taylor MD, Rutka JT. Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma. Oncotarget. 2015; 6(25):21718-21729.

Park JB, Agnihotri S, Golbourn B, Bertrand KC, Luck A, Sabha N, Smith CA, Byron S, Zadeh G, Croul S, Berens M, Rutka JT. Transcriptional profiling of GBM invasive genes identifies effective inhibitors of the LIM kinase-cofilin pathway. Oncotarget. 2014; 5(19):9382-95.

Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jäger N, Jones DT, Sill M, Pugh TJ, Ryzhova M, Wani KM, Shih DJ, Head R, Remke M, Bailey SD, Zichner T, Faria CC, Barszczyk M, Stark S, Seker-Cin H, Hutter S, Johann P, Bender S, Hovestadt V, Tzaridis R, Dubuc AM, Northcott PA, Peacock J, Bertrand KC, et al. Epigenetic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014; 506(7489):445-450.

Pinkham MB, Bertrand KC, Olson S, Zarate D, Oram J, Pullar A, Foote MC. Hippocampal-sparing radiotherapy: the new standard of care for gliomas. Journal of Clinical Neuroscience. 2014; 21(1):86-90.

Mack, SC, Witt, H, Wang X, Milde, T, Yao, Y, Bertrand KC, Korshunov, A, Pfister, SM, Taylor MD. Emerging Insights into the Ependymoma Epigenome. Brain Pathology. 2013; 23(2):206-209.

Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, Benner A, Hielscher T, Milde T, Remke M, Jones DT, Northcott PA, Garzia L, Bertrand KC, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011; 20(2):143-157.

Bertrand KC, Mack SC, Northcott PA, Garzia L, Dubuc A, Pfister SM, Rutka JT, Weiss WA, Taylor MD. PCDH10 is a candidate tumour suppressor gene in Medulloblastoma. Childs Nerv Syst. 2011; 27(8):1243-1249.

Shahrzad S, Bertrand K, Minhas K, Coomber BL. Induction of DNA Hypomethylation by Tumor Hypoxia. Epigenetics 2007; 2(2):119-125.

View publications on PubMed